Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹3,695 Cr
Revenue (TTM)
₹2,419 Cr
Net Profit (TTM)
₹338 Cr
ROE
22.6 %
ROCE
25.3 %
P/E Ratio
10.9
P/B Ratio
1.7
Industry P/E
21.88
EV/EBITDA
7.1
Div. Yield
0.7 %
Debt to Equity
0.3
Book Value
₹496.1
EPS
₹78.3
Face value
10
Shares outstanding
43,141,338
CFO
₹2,890.18 Cr
EBITDA
₹3,705.71 Cr
Net Profit
₹1,844.48 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Epigral
| -30.0 | -13.8 | -39.0 | -51.9 | -1.3 | -- | -- |
|
BSE Commodities
| -2.3 | -5.5 | 0.6 | 12.2 | 16.1 | 13.6 | 16.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Epigral
| -34.9 | 93.2 | -21.7 | 64.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Epigral
|
854.1 | 3,694.8 | 2,418.7 | 337.7 | 17.0 | 16.9 | 10.9 | 1.7 |
| 1,350.1 | 6,903.7 | 1,535.0 | 180.7 | 13.7 | 12.7 | 38.2 | 4.6 | |
| 3,424.0 | 14,848.9 | 15,069.6 | 378.2 | 3.0 | 9.9 | 39.3 | 3.8 | |
| 943.4 | 11,941.8 | 11,162.0 | 877.2 | 12.4 | 13.7 | 13.6 | 1.8 | |
| 1,730.2 | 6,144.8 | 5,078.5 | 280.8 | 7.1 | 11.9 | 21.9 | 2.4 | |
| 451.2 | 4,150.8 | 3,055.2 | 507.1 | 20.3 | 14.2 | 8.2 | 1.2 | |
| 2,549.5 | 8,181.3 | 15,622.2 | 1,787.5 | 16.6 | 12.6 | 9.1 | 1.0 | |
| 4,229.1 | 5,781.0 | 1,886.6 | 168.0 | 11.4 | 16.6 | 34.4 | 4.3 | |
| 6,337.5 | 32,471.4 | 3,077.1 | 545.9 | 25.9 | 18 | 59.5 | 8.6 | |
| 650.5 | 16,568.1 | 14,655.0 | 194.0 | 4.8 | 1.2 | 92 | 0.7 |
No Review & Analysis are available.
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda,... chlorine, hydrogen, and caustic potash products. It also engages in the trading of agrochemical products. It serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India. Read more
Incorporated
2007
Chairman
Maulik Patel
Managing Director
Maulik Patel
Group
Meghmani
Headquarters
Ahmedabad, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Epigral Ltd is ₹854.10 (NSE) and ₹856.45 (BSE) as of 18-Mar-2026 IST. Epigral Ltd has given a return of -1.3% in the last 3 years.
The P/E ratio of Epigral Ltd is 10.93 times as on 18-Mar-2026, a 50 discount to its peers’ median range of 21.88 times.
The P/B ratio of Epigral Ltd is 1.73 times as on 18-Mar-2026, a 12 premium to its peers’ median range of 1.54 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
22.90
|
4.30
|
|
2024
|
23.25
|
3.63
|
|
2023
|
11.09
|
3.67
|
|
2022
|
16.01
|
5.57
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Epigral Ltd are Rs 2,114.00 and Rs 822.50 as of 19-Mar-2026.
Epigral Ltd has a market capitalisation of ₹ 3,695 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Epigral Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹0.75
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.